Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of abciximab. We present a case which was managed su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, Soonyoung, Lee, Jooyoung, Lee, Sang Yeub, Bae, Jang-Whan, Hwang, Kyung-Kuk, Kim, Dong-Woon, Cho, Myeong-Chan, Kim, Sang Min
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Cardiology 2013
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772301/
https://ncbi.nlm.nih.gov/pubmed/24044015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2013.43.8.557
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados